Objective-Macrophage apoptosis plays important roles in atherosclerosis. Bcl-2 is a key cell survival molecule, but its role in macrophage apoptosis in atherosclerosis is not known. The goal herein was to determine the effect of macrophage-targeted deletion of Bcl-2 on macrophage apoptosis in atherosclerotic lesions of Apoe Ϫ/Ϫ mice. Methods and Results-Bcl2 flox -LysMCre mice were created as a model of macrophage Bcl-2 deficiency. Macrophages from these mice were more susceptible to apoptosis than those from control Bcl2 WT -LysMCre mice. The mice were bred onto the Apoe Ϫ/Ϫ background and fed a Western-type diet for 4 or 10 weeks. Apoptotic cells were equally very rare in the lesions of both groups of the 4-week-diet mice, and there was no difference in lesion area. However, Bcl2 flox -LysMCre;Apoe Ϫ/Ϫ plaques from the 10-week-diet protocol had a 40% to 45% increase in apoptotic cells and, in female mice, a Ϸ25% increase in plaque necrosis (PϽ0.05) compared with Bcl2 WT -LysMCre lesions. Key Words: atherosclerosis-pathophysiology Ⅲ apoptosis Ⅲ macrophage Ⅲ animal models of human disease M acrophage apoptosis can be a critical event in atherosclerosis and occurs at all stages of disease development. 1 In early lesions, macrophage apoptosis is associated with a decrease in lesion cellularity and plaque progression, 2,3 which could be attribtuable to rapid phagocytic clearance or egress of the apoptotic cells or decreased influx of macrophages. In advanced lesions, however, clearance of apoptotic cells is defective, which leads to secondary necrosis of apoptotic cells. 4 -6 Accordingly, we have proposed that macrophage apoptosis in advanced lesions leads to plaque necrosis, which is thought to promote plaque disruption and acute clinical events in humans. 7 In support of this idea, vulnerable necrotic human plaques have increased macrophage apoptosis. 8 Moreover, genetic or pharmacological manipulations that decrease macrophage apoptosis in advanced murine lesions decrease plaque necrosis, and vice versa. 9
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Bcl-2 has been on the forefront of cell survival signaling since its discovery more than 20 years ago, yet there is an absence of in vivo causation studies assessing the role of Bcl-2 in atherosclerosis using genetically altered mouse models. This point is critical, because there are a number of other cell survival molecules in lesional cells, including Bcl-xL, apoptosis inhibitor expressed by macrophages (AIM; SP␣), Mcl-1, and members of the inhibitor-of-apoptosis (IAP) family, and so redundancy might negate the effect of deletion of any one cell survival molecule. Because Bcl-2 is expressed in other lesional cell types and holo-Bcl2 Ϫ/Ϫ mice have multiple abnormalities at birth, 10 we created macrophage-targeted Bcl-2-deficient mice and studied the effect of this mutation on atherosclerosis in Western diet-fed Apoe Ϫ/Ϫ mice. Our studies indicate that macrophage Bcl-2 plays a protective role against macrophage apoptosis specifically in advanced atherosclerotic lesions. Moreover, in the more advanced lesions of female mice, macrophage Bcl-2 also has a modest protective effect against plaque necrosis.
Materials and Methods
Materials and methods related to cultured macrophages, genetically altered mice, plasma lipid analysis, laser capture microdissection, quantification of atherosclerotic lesions, and statistics appear in the supplemental materials (available online at http://atvb.ahajournals.org).
In Situ TUNEL Assays and Plaque Necrosis
Apoptotic cells in atherosclerotic lesions were detected by the TUNEL (TdT-mediated dUTP nick end labeling) technique using the TMR red in situ cell death detection kit (Roche). Nuclei were stained with DAPI. TUNEL-positive nuclei were counted under an Olympus IX-70 inverted fluorescent microscope. For assessment of macrophage colocalization, macrophages were detected using a rabbit antimacrophage antibody (AIA31240) from Accurate Chemical and Scientific Corporation, and nuclei were stained with Hoechst. Plaque necrosis was quantified by measuring the area of hematoxylin and eosin-negative acellular areas in the intima, as described previously. 11 Background data for the 10-week-diet study are described in supplemental Results and supplemental Figure II . Figure  1A demonstrates and increase in TUNEL-positive nuclei, a measure of apoptosis, in Bcl2 flox -LysMCre;Apoe Ϫ/Ϫ versus Bcl2 WT -LysMCre;Apoe Ϫ/Ϫ lesions. As expected, the areas of TUNEL staining correlated with macrophage-rich areas in these lesions ( Figure 1B) . The quantified data for the full cohort of mice is shown in Figure 1C . Examples of hematoxylin and eosin-stained aortic root sections of from female Bcl2 WT -LysMCre;Apoe Ϫ/Ϫ and Bcl2 flox -LysMCre;Apoe Ϫ/Ϫ mice are shown in Figure 2A . Total lesion area per se was not affected by macrophage Bcl-2 depletion ( Figure 2B ). Also not affected by macrophage Bcl2 deficiency were plasma levels of tumor necrosis factor (TNF)␣ and interleukin (IL)-6 (data not shown). Increases in macrophage apoptosis are translated into increases in plaque necrosis only after further lesion progres- The differences between female vs male lesions in both genotypes are statistically different by Mann-Whitney analysis (PϽ0.05). C, Quantification of crosssectional necrotic area. Asterisk, PϽ0.05. D, Individual plaques in aortic root cross sections from female mice were separated into two groups based on plaque area, Ͻ200 000 and Ͼ200 000 m 2 , and then analyzed for plaque necrosis For each mouse, 6 cross sections were analyzed, and each section had, on average, 3 individual plaques. The differences in necrotic area between larger and smaller plaques for each genotype were statistically significant (PϽ0.001 by Mann-Whitney).
Results
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sion. 12 In the current study, the female mice as a group had larger and more advanced lesions than male mice, and female Bcl2 flox -LysMCre;Apoe Ϫ/Ϫ lesions appeared to have more acellular necrotic areas (black arrows in Figure 2A ) as well as necrotic areas with cholesterol crystals (red arrows in Figure  2A ). Quantification showed a Ϸ25% increase in necrotic area in Bcl2 flox -LysMCre;Apoe Ϫ/Ϫ versus Bcl2 WT -LysMCre;Apoe Ϫ/Ϫ female mice (PϽ0.05) ( Figure 2C ). Neither fibrous cap thickness nor lesional collagen content were affected by macrophage Bcl-2 deficiency (data not shown).
The difference in the affect of macrophage Bcl-2 deficiency on plaque necrosis could be attributable to a direct effect of sex differences, eg, sex steroids, or to the fact that female lesions were more advanced (see Figure 2B) . 12 In an attempt to sort out these possibilities, individual plaques from the female mice were divided into 2 subgroups based on plaque area: Ͻ200 000 and Ͼ200 000 m 2 . We found a statistically significant difference in necrotic area between the genotypes only in the larger plaque subgroup (Table in Figure  2D ). This finding is consistent with the conclusion that macrophage Bcl-2 deficiency has a selective effect on more advanced lesions. There were not enough larger plaques among the male lesions for analysis, and so pending future studies with more advanced male lesions, there is also the possibility of a direct sex effect as well. In summary, macrophage Bcl-2 deficiency is associated with increased advanced lesional macrophage apoptosis and, in large lesions in female mice, an increase in plaque necrosis.
Discussion
See supplemental materials for a discussion of the findings in this report in relationship to relevant articles in the literature.
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